WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing two Phase 2 small-molecule programs for immunological, inflammatory, and ...

Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in adult SLE alongside corticosteroids, antimalarials, and/or immunosuppressants ...

Please provide your email address to receive an email when new articles are posted on . Enpatoran bested placebo in CLASI-50 and CLASI-70 at 16 and 24 weeks. The oral small molecule toll-like receptor ...

In a new study, researchers examined four randomized controlled trials of belimumab (Benlysta®) to gain a better understanding of systemic lupus erythematosus (SLE) active disease progression with the ...